p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors.
about
Epigenetic modulation with HDAC inhibitor CG200745 induces anti-proliferation in non-small cell lung cancer cellsProtective Effects of Valproic Acid, a Histone Deacetylase Inhibitor, against Hyperoxic Lung Injury in a Neonatal Rat ModelThe novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilizationHistone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epitheliumThe histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathwaysNovel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro.Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding.Natural products as zinc-dependent histone deacetylase inhibitors.HDACs and HDAC Inhibitors in Cancer Development and Therapy.HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer.Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines.Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53.The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing's sarcoma cell line.Cell Signaling Model Connects Vorinostat Pharmacokinetics and Tumor Growth Response in Multiple Myeloma Xenografts.Assessment of HDACi-Induced Cytotoxicity.Regulation of expression of the p21CIP1 gene by the transcription factor ZNF217 and MDM2.Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.HDAC inhibitors show differential epigenetic regulation and cell survival strategies on p53 mutant colon cancer cells.KH-TFMDI, a novel sirtuin inhibitor, alters the cytoskeleton and mitochondrial metabolism promoting cell death in Leishmania amazonensis.
P2860
Q28544442-25831A73-05C0-4BAB-9796-3DEBDE147E07Q28546994-F5DA0493-3105-4FDF-B34B-B524FAB35D68Q33776640-C9CB6012-B99C-443E-B8A7-D0E3B8738796Q35059923-D44625BC-1B40-41DD-9729-EBCE86E1EA08Q35178908-5BCE483A-B547-41AF-A2AA-E4BF9C6CD8ECQ36157305-29C2DF99-CF05-4CD1-9AF0-AF7D7ACC85B5Q36729432-BCC5FA8B-DAC9-4928-922F-13614B09525CQ36853881-9EABB5D4-3132-40DE-91E7-A4C307A29565Q37513949-C1B2B200-3AF4-4D4D-AB6A-6CBFEF784906Q38315538-45B7A426-B717-40B6-9FB3-D5F88E53139EQ38947405-68279F98-7E7A-4929-A487-05ED93FA1A45Q39307665-0ABE2BD9-FF89-4490-AC26-CB7192C77A8BQ42701542-BA8DCB0E-F2EA-438D-9E5C-5149E80E8C19Q44948239-591A1870-4C0D-4D72-909E-CBD8EB2D95BCQ46038047-92756F15-CD65-4A08-B1CA-3BEAF4431D15Q46259205-E99422A2-2DD5-40F1-80A4-E07F9CF4450EQ47633998-38FB8E7B-4476-4AC6-8166-09499EE66848Q50196119-C74935ED-CC90-427B-9A3F-814E311317A4Q51357208-12DEF934-DE52-41ED-945A-110EE95C0D02Q51374040-8B1C427A-F06E-42C8-9DC1-7A825CADA5DFQ52579667-BADB7D13-51C3-403B-B204-233FD933ED44Q52707747-2D655ED6-B050-4BBA-B98D-756A519BE62FQ52763318-14236981-8EC5-4446-A9C5-A7752BAB2003
P2860
p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
p53-dependent and p53-independ ...... istone deacetylase inhibitors.
@en
p53-dependent and p53-independ ...... istone deacetylase inhibitors.
@nl
type
label
p53-dependent and p53-independ ...... istone deacetylase inhibitors.
@en
p53-dependent and p53-independ ...... istone deacetylase inhibitors.
@nl
prefLabel
p53-dependent and p53-independ ...... istone deacetylase inhibitors.
@en
p53-dependent and p53-independ ...... istone deacetylase inhibitors.
@nl
P2093
P2860
P356
P1476
p53-dependent and p53-independ ...... histone deacetylase inhibitors
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2013.742
P407
P577
2013-11-26T00:00:00Z